Background: The adenoid is involved in the defence against airway pathogens and its surface is also exposed to airborne allergens. The knowledge about reactions taking place in the lymphatic tissue of this organ is, however, limited. To elucidate the influence of atopy we investigated the cellular and cytokine profile of in vitro-stimulated adenoid lymphocytes. Methods: Adenoid tissue cells from 13 atopic and 8 non-atopic children were cultured and stimulated with ionomycin and 4β-phorbol 12-myristate 13-acetate. Supernatants were collected after 4 and 20 h of stimulation and interleukin-2 (IL-2), IL-4 and interferon-γ (IFN-γ) were analysed by ELISA. Flow cytometry was used to quantify the leukocyte markers CD3, CD19, CD25 and HLA-DR. Results: Increased levels of IL-2 and IL-4 but not IFN-γ were detected in the supernatants of adenoid cell cultures from atopic children after 20 h of stimulation (p < 0.05) and a significant correlation with a positive regression between IL-2 and IL-4 was found. Atopy was also associated with a greater increase in the percentage of CD19-positive B cells after stimulation (p < 0.05). Conclusions: A difference in the reactivity of adenoidal lymphoid cells in children was observed between atopic and non-atopic subjects. Atopy was associated with an increased production of IL-2 and IL-4 as well as a more pronounced increase of B cells.

Keywords:
Adenoid, Allergy, Flow cytometry, Interleukin-2, Interleukin-4, Lymphocyte, B cells, 4β-Phorbol 12-myristate 13-acetate, Ionomycin
1.
van Kempen MJ, Rijkers GT, Van Cauwenberge PB: The immune response in adenoids and tonsils. Int Arch Allergy Immunol 2000;122:8–19.
2.
Brandtzaeg P: Regionalized immune function of tonsils and adenoids. Immunol Today 1999;20:383–384.
3.
Jahnsen FL, Brandtzaeg P: Antigen presentation and stimulation of the immune system in human airways. Allergy 1999;54(suppl 57):37–49.
4.
Quiding M, Lakew M, Granstrom G, Nordstrom I, Holmgren J, Czerkinsky C: Induction of specific antibody responses in the human nasopharyngeal mucosa. Adv Exp Med Biol 1995;371B:1445–1450.
5.
Perry M, Whyte A: Immunology of the tonsils. Immunol Today 1998;19:414–421.
6.
Papatziamos G, van der Ploeg I, Hemlin C, Patwardhan A, Scheynius A: Increased occurrence of IgE+ and FcepsilonRI+ cells in adenoids from atopic children. Allergy 1999;54:916–925.
7.
Astrom K, Papatziamos G, Magnusson CG, Hemlin C, Scheynius A, van der Ploeg I: Analysis of epsilon germline transcripts and IL-4 mRNA expression in the adenoids suggests local IgE switching. Allergy 2000;55:1049–1055.
8.
Ganzer U, Bachert C: Localization of IgE synthesis in immediate-type allergy of the upper respiratory tract. ORL J Otorhinolaryngol Relat Spec 1988;50:257–264.
9.
Loesel LS: Detection of allergic disease in adenoid tissue. Am J Clin Pathol 1984;81:170–175.
10.
Vinke JG, Fokken WJ: The role of the adenoid in allergic sensitisation. Int J Pediatr Otorhinolaryngol 1999;49(suppl 1):S145–S149.
11.
Johansson SG, Hourihane JO, Bousquet J, Bruijnzeel-Koomen C, Dreborg S, Haahtela T, Kowalski ML, Mygind N, Ring J, van Cauwenberge P, Hage-Hamsten M, Wuthrich B: A revised nomenclature for allergy. An EAACI position statement from the EAACI nomenclature task force. Allergy 2001;56:813–824.
12.
Lagging E, Papatziamos G, Hallden G, Hemlin C, Harfast B, Hage-Hamsten M: T-cell subsets in adenoids and peripheral blood related to age, otitis media with effusion and allergy. APMIS 1998;106:354–360.
13.
Hemlin C, Hallden G, Hed J: Flow cytometric quantification of lymphocyte subpopulations and immunoglobulin-containing cells in adenoid tissue in relation to secretory otitis media and age. Acta Otolaryngol 1995;115:443–448.
14.
Forsgren J, Rynnel-Dagoo B, Christensson B: In situ analysis of the immune microenvironment of the adenoid in children with and without secretory otitis media. Ann Otol Rhinol Laryngol 1995;104:189–196.
15.
Harabuchi Y, Hamamoto M, Kodama H, Kataura A: Spontaneous immunoglobulin production by adenoidal and tonsillar lymphocytes in relation to age and otitis media with effusion. Int J Pediatr Otorhinolaryngol 1996;35:117–125.
16.
van Nieuwkerk EB, de Wolf CJ, Kamperdijk EW, van der Baan S: Lymphoid and non-lymphoid cells in the adenoid of children with otitis media with effusion: A comparative study. Clin Exp Immunol 1990;79:233–239.
17.
Bernstein JM, Rich GA, Odziemiec C, Ballow M: Are thymus-derived lymphocytes (T cells) defective in the nasopharyngeal and palatine tonsils of children? Otolaryngol Head Neck Surg 1993;109:693–700.
18.
Bernstein JM, Ballow M, Xiang S, O’Neil K: Th1/Th2 cytokine profiles in the nasopharyngeal lymphoid tissues of children with recurrent otitis media. Ann Otol Rhinol Laryngol 1998;107:22–27.
19.
Richtsmeier WJ: Human interferon production in tonsil and adenoid tissue cultures. Am J Otolaryngol 1983;4:325–333.
20.
Boyaka PN, Wright PF, Marinaro M, Kiyono H, Johnson JE, Gonzales RA, Ikizler MR, Werkhaven JA, Jackson RJ, Fujihashi K, Di Fabio S, Staats HF, McGhee JR: Human nasopharyngeal-associated lymphoreticular tissues. Functional analysis of subepithelial and intraepithelial B and T cells from adenoids and tonsils. Am J Pathol 2000;157:2023–2035.
21.
Prussin C: Cytokine flow cytometry: Understanding cytokine biology at the single-cell level. J Clin Immunol 1997;17:195–204.
22.
Andersson U, Andersson J, Lindfors A, Wagner K, Moller G, Heusser CH: Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes. Eur J Immunol 1990;20:1591–1596.
23.
Rostaing L, Tkaczuk J, Durand M, Peres C, Durand D, de Preval C, Ohayon E, Abbal M: Kinetics of intracytoplasmic Th1 and Th2 cytokine production assessed by flow cytometry following in vitro activation of peripheral blood mononuclear cells. Cytometry 1999;35:318–328.
24.
Bernstein JM, Ballow M, Rich G: Detection of intracytoplasmic cytokines by flow cytometry in adenoids and peripheral blood lymphocytes of children. Ann Otol Rhinol Laryngol 2001;110:442–446.
25.
Lindberg K, Rynnel-Dagoo B, Sundqvist KG: Cytokines in nasopharyngeal secretions; evidence for defective IL-1 beta production in children with recurrent episodes of acute otitis media. Clin Exp Immunol 1994;97:396–402.
26.
Jenkins MK, Khoruts A, Ingulli E, Mueller DL, McSorley SJ, Reinhardt RL, Itano A, Pape KA: In vivo activation of antigen-specific CD4 T cells. Annu Rev Immunol 2001;19:23–45.
27.
Duprez V, Cornet V, Dautry-Varsat A: Down-regulation of high affinity interleukin 2 receptors in a human tumor T cell line. Interleukin 2 increases the rate of surface receptor decay. J Biol Chem 1988;263:12860–12865.
28.
Musiatowicz M, Wysocka J, Kasprzycka E, Hassmann E: Lymphocyte subpopulations in hypertrophied adenoid in children. Int J Pediatr Otorhinolaryngol 2001;59:7–13.
29.
Hemlin C, Carenfelt C, Hallden G, Hed J, Scheynius A: Adenoid tissue lymphocyte subpopulations – Evaluation of a quantitative analysis with flow cytometry. APMIS 1993;101:551–556.
30.
Mattila PS, Tarkkanen J: Age-associated changes in the cellular composition of the human adenoid. Scand J Immunol 1997;45:423–427.
31.
Vinke JG, Kleinjan A, Severijnen LW, Hoeve LJ, Fokkens WJ: Differences in nasal cellular infiltrates between allergic children and age-matched controls. Eur Respir J 1999;13:797–803.
32.
Fokkens WJ, Vinke JG, De Jong SS, Bogaert DP, Kleinjan A, Eichhorn E: Differences in cellular infiltrates in the adenoid of allergic children compared with age- and gender-matched controls. Clin Exp Allergy 1998;28:187–195.
© 2003 S. Karger AG, Basel
2004
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.